临床试验登记· VA Office of Research and Development · ClinicalTrials.gov·· 11 小时前评分30
Tocilizumab联合一线化疗-免疫治疗用于转移性非小细胞肺癌
Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer
导读
VA Office of Research and Development登记NCT07889232，评估Tocilizumab联合Pembrolizumab及铂类双药化疗一线治疗转移性非小细胞肺癌。该1b/2期单臂研究计划入组43人，纳入伴明显体重或肌肉量下降者，目前尚未招募。
来源：临床试验登记 · clinicaltrials.gov